/ Unlabelled / Global Type 2 Diabetes Market 2016-2020 – Low Diagnosis Rate Poses Challenge for Market – Research and Markets – PR Newswire (press release)

Monday, July 4, 2016

Global Type 2 Diabetes Market 2016-2020 – Low Diagnosis Rate Poses Challenge for Market – Research and Markets – PR Newswire (press release)

Date - 

DUBLIN, July 4, 2016 /PRNewswire/ —

Research and Markets has actually announced the addition of the “Global Form two Diabetes Market 2016-2020” report to their offering.

     (Logo: http://ift.tt/1UURArF )

The global Form two diabetes drugs market is expected to plant at a CAGR of 7.28% throughout the time period 2016-2020.

Diabetes, frequently called diabetes mellitus, is a metabolic health problem in which the patients’ blood sugar levels remains high. Depending on the subject of the trigger of progress of diabetes, it can easily be divided in to 3 types:

  • Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas do not create the needed quantity of insulin, best to higher blood sugar levels.
  • Type two diabetes (non-insulin dependent diabetes mellitus): In this condition, though the physique creates the needed quantity of insulin, the cells do not respond to it, increasing the sugar levels in the body.
  • Gestational diabetes: This condition occurs in pregnant women free of any sort of prior history of diabetes

The growing awareness of Form two diabetes and the therapies offered for it, as a outcome of national and global initiatives, steers the market. The raise in the diabetic population has actually increased accessibility to health problem monitoring and health problem management devices, and essential vendors have actually begun to concentrate on emerging markets such as China.

According to the report, obesity, undesirable diets, and shortage of bodily task have actually increased the variety of diabetes cases worldwide. As reported by WHO, it was estimated that 9% of the grownups That are 18 years and above had diabetes in 2014. It was additionally reported that the global prevalence of diabetes would certainly be about 36six million by 2030. In 2013, nearly 21 million live births were afflicted by diabetes throughout pregnancy. An raise in the exposure to the risk factors for Form two diabetes in low- and middle-income teams is increasing in Middle East, North Africa, Southeast Asian, and Western Pacific regions.

Further, the report states that reasonable diagnosis price impedes individuals from availing the treatment, posing a challenge for the market.

Key vendors: 

  • AstraZeneca plc
  • Eli Lilly and Company
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • Sanofi SA

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market Study methodology

PART 04: Introduction

PART 05: health problem overview

PART 06: Pipeline portfolio

PART 07: Market landscape

PART 08: Market segmentation by drug class

PART 09: Insulin

PART 10: DPP-4 inhibitors

PART 11: GLP-1 receptor agonists

PART 12: SGLT-two inhibitors

PART 13: Geographical segmentation

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

For a lot more write-up visit http://ift.tt/29ry5XV

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hrs Call 1-917-300-0470
For U.S./can easily Toll Free Call 1-800-526-8630
For GMT Office Hrs Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Study and Markets

Share this